Maximus (NYSE:MMS) Posts Quarterly Earnings Results, Beats Expectations By $0.26 EPS

Maximus (NYSE:MMS – Get Free Report) announced its earnings results on Thursday. The health services provider reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.26, Zacks reports. Maximus had a net margin of 7.07% and a return on equity of 24.91%. Maximus updated its FY 2027 guidance to 7.500-8.000 EPS.

Maximus Stock Performance

Shares of Maximus stock opened at $65.26 on Thursday. The company has a market capitalization of $3.42 billion, a PE ratio of 9.64 and a beta of 0.57. The company has a 50-day simple moving average of $59.97 and a two-hundred day simple moving average of $63.12. Maximus has a one year low of $51.04 and a one year high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a $0.33 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.32 dividend on an annualized basis and a yield of 2.0%. Maximus’s payout ratio is currently 19.50%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MMS. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Weiss Ratings restated a “hold (c-)” rating on shares of Maximus in a report on Friday, November 13th. Finally, Zacks Research raised shares of Maximus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 1st. Two equities research analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Maximus has an average rating of “Hold”.

View Our Latest Analysis on MMS

Insider Buying and Selling at Maximus

In other news, insider Michelle Link sold 3,208 shares of the firm’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $54.23, for a total value of $173,969.84. Following the sale, the insider directly owned 13,881 shares in the company, valued at approximately $752,766.63. This trade represents a 18.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

About Maximus

(Get Free Report)

Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.

Read More

Earnings History for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.